NEW YORK (GenomeWeb News) – Response Biomedical said today that it has grossed C$12.7 million ($11.1 million) through a public offering, and it plans to use the funds for general operating costs and for capital acquisitions.

The company said it issued 73,333,333 units at a price of C$0.15 per unit, and that it concurrently issued an additional 11 million units pursuant to the exercise-in-full of an over-allotment option it granted to the underwriter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.